#BioRxiv

Roman Link

RomanMLink

Please check out the preprint of my upcoming shared first-author paper with Peter Hajek. We studied the death of thousands of young trees in a tree diversity experiment during the

Kevin McKernan 🙂

Kevin_McKernan

OK Koch heads... bring your hurt.I’m glad you folks exist as we need people questioning everything.However, I have found the “virus doesn’t exist” arguments unconvincing. The virus isn’t the only

Nick Burton

BurtonNick

It’s been a big two weeks in the field of multigenerational effects in C. elegans with four different papers published or up on bioRxiv in a two-week window! Still reading

Alina Chan

Ayjchan

Going to briefly discuss a new SARS-CoV-2 preprint by the FDA, whose senior author said "was intended to investigate something that could only have happened in a laboratory" according to

Ben Kamens

kamens

0/ The search for COVID-19 therapies should revolve around a single question that’s staring us right in the face, and we’re mostly ignoring it: 1/ Why are COVID-19 outcomes *dramatically*

Dan Goodman

neuralreckoning

Have you ever wondered why neurons are like snowflakes? No two alike, even if they're the same type. In our latest preprint, we think we have (at least part of)

Imran S. Haque

ImranSHaque

Happy Monday! In today's #tweetorial on our recent preprint describing @RecursionPharma's platform (https://www.biorxiv.org/content/10.1101/2020.08.02.233064v1), I'll explain the unusual 2-D drug response plots we use there and

Adam Kucharski

AdamJKucharski

Coverage of disease modelling tends to focuses on population-level 'what could happen next?' scenario analyses and predictions. So I wanted to highlight some early COVID-19 insights that you've probably heard

Marco Hein 😷

marcoyannic

Fresh #herpesvirus content:1/ We posted an updated preprint of our #singlecell functional genomics study of human #cytomegalovirus infection.I didn't do a tweetorial with the initial version, so here it comes

Ryan Z Friedman

rfriedman22

My first preprint with @genologos and Barak Cohen is on @biorxivpreprint today!We came up with an information content metric which can classify functional enhancers vs silencers nearly as well as

Lucre Snooker

LucreSnooker

might fuck around and do a long detailed t-cell thread there's a lovely new paper that sheds a lot of light on CD8+ (aka killer/cytotoxic) T cells in COVID-19 and

Tracey Weissgerber

T_Weissgerber

I wanted to share links to some resources that I mentioned during yesterday's Danube Epigenetics webinar.If you're new to designing figures and you're not sure where to start, take 2

Sylvia Villeneuve

sylv_villeneuve

1/14 Once upon a time (>2 years ago), we started the journey of making the PREVENT-AD data open. We had to reconsent the participants, develop the platform to host and

Are you up4BUIA? (Bottom-Up Interdisciplinarity)

Seempleetoo

"They all developed anti-SARS-CoV-2 antibodies and a significant T cell response detectable up to 69 days after symptom onset... Six out of eight contacts developed a SARS-CoV-2-specific T cell response

A Marm Kilpatrick

DiseaseEcology

Will vaccination of health care workers (HCWs) lead to accidental silent spreading of COVID-19?Big possible downside to vaccine allocation recommendations w/out data on whether vaccines reduce infectiousness.Thread The justification for

Eric Feigl-Ding

DrEricDing

REINFECTION WARNING from the WHO. “We are now getting reports of people getting reinfected with a new variant—from (#B1351)—suggesting people who’ve had prior infection could get infected again.” says

By continuing to use the site, you are consenting to the use of cookies as explained in our Cookie Policy to improve your experience.